Novel Cancer Therapeutics

Study on cracking, fatigue and fracture, especially in active environments as well as corrosion and anticorrosion protection of structural metallic and polymer materials, and the development of new materials.

Cancer Biomarkers and Diagnostics

Electrophoretic deposition (EPD) is one of the colloidal processes in ceramic production and has advantages of short formation time, needs simple apparatus, little restriction of the shape of substrate, no requirement for binder burnout as the green coating contains few or no organics.

Cancer Immunology and Immune-oncology

EPD is a fast and efficient method to produce organic/inorganic coatings on metallic substrates. With simple adjustment of the applied potential, deposition time and suspension composition it is possible to control the thickness and microstructure of the deposited films. EPD offers many possibilities in terms of surface modifications of metallic materials for medical applications.

Cancer Prevention and Early Detection

Nanoscale assemblies are a unique class of materials, which can be synthesized from inorganic, polymeric or biological building blocks. The multitude of applications of this class of materials ranges from solar and electrical to uses in food, cosmetics and medicine.

Clinical Trials in Cancer Therapy and Immunotherapy

Electrophoretic deposition has been effectively utilized within the field of nanoenergetic materials. EPD exploits the mechanisms of electrophoresis where the influence of an electric field induces the motion of colloidal particles suspended in a liquid based on their surface charge and results in their accumulation on conductive substrates submerged in the colloid.

Risk Factor Epidemiology

The recent applications of EPD includes composite materials, laminates, nanomaterials, functionally graded materials, materials for solid oxide fuel cells, nanostructured materials, carbon nanotubes and graphene, biomaterials, etc.

Genomic and Genetic Testing for Cancer

Genomic testing can be used to analyze the DNA of your tumor and may identify the genetic mutations that are unique to your cancer. Identifying the mutations in a patient's cancer is the key to developing personalized treatments.

Cancer Health Disparities

Submissions that explore the determinants of differences in cancer prevalence, mortality, survivorship, and burden among specific population groups. Studies that examine outcomes of interventions to address disparities at individual, clinical, and community levels are also of interest

Implementation Science & Cancer Care Delivery

Submissions focusing on research to improve the quality of cancer care by understanding and intervening on patient, clinician, and health system factors involved in care delivery, as well as studies examining the impact of cancer control and population science on the health and health care of the population, and fostering the rapid integration of research, practice, and policy, across the cancer continuum.